[1]
Price, L.C. et al. 2024. Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 41, 1 (Mar. 2024), e2024024. DOI:https://doi.org/10.36141/svdld.v41i1.15515.